drugset / Trial / NCT00019864

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

NCT00019864

Phase 2 Terminated 100 enrolled National Cancer Institute (NCI)
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. Giving chemotherapy after surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving chemotherapy before and after surgery works in treating patients with osteosarcoma.

Timeline

Start
2000-03
Primary completion
2006-12
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Methotrexate Small molecule Intravenous
Background Dexrazoxane Small molecule Intravenous
Background Leucovorin Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous